nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—SLC47A1—Mitoxantrone—sarcoma	0.504	0.607	CbGbCtD
Cephalexin—SLC22A5—Dactinomycin—sarcoma	0.183	0.22	CbGbCtD
Cephalexin—CYP3A4—Thiotepa—sarcoma	0.0578	0.0697	CbGbCtD
Cephalexin—CYP3A4—Mitoxantrone—sarcoma	0.0249	0.03	CbGbCtD
Cephalexin—CYP3A4—Vincristine—sarcoma	0.0171	0.0206	CbGbCtD
Cephalexin—CYP2D6—Doxorubicin—sarcoma	0.0168	0.0203	CbGbCtD
Cephalexin—CYP3A4—Etoposide—sarcoma	0.0157	0.0189	CbGbCtD
Cephalexin—CYP3A4—Doxorubicin—sarcoma	0.0107	0.0129	CbGbCtD
Cephalexin—Pancytopenia—Etoposide—sarcoma	0.000724	0.00425	CcSEcCtD
Cephalexin—Blood bilirubin increased—Epirubicin—sarcoma	0.00072	0.00422	CcSEcCtD
Cephalexin—Jaundice cholestatic—Doxorubicin—sarcoma	0.000717	0.00421	CcSEcCtD
Cephalexin—Creatinine increased—Epirubicin—sarcoma	0.000716	0.0042	CcSEcCtD
Cephalexin—Neutropenia—Etoposide—sarcoma	0.000713	0.00418	CcSEcCtD
Cephalexin—Arthropathy—Doxorubicin—sarcoma	0.000693	0.00406	CcSEcCtD
Cephalexin—Vaginal inflammation—Epirubicin—sarcoma	0.000681	0.00399	CcSEcCtD
Cephalexin—Phosphatase alkaline increased—Epirubicin—sarcoma	0.000681	0.00399	CcSEcCtD
Cephalexin—Infestation NOS—Etoposide—sarcoma	0.00068	0.00399	CcSEcCtD
Cephalexin—Infestation—Etoposide—sarcoma	0.00068	0.00399	CcSEcCtD
Cephalexin—Agitation—Thiotepa—sarcoma	0.00068	0.00399	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Etoposide—sarcoma	0.000674	0.00395	CcSEcCtD
Cephalexin—Blood bilirubin increased—Doxorubicin—sarcoma	0.000666	0.00391	CcSEcCtD
Cephalexin—Creatinine increased—Doxorubicin—sarcoma	0.000662	0.00388	CcSEcCtD
Cephalexin—Leukopenia—Thiotepa—sarcoma	0.000662	0.00388	CcSEcCtD
Cephalexin—Mental disorder—Vincristine—sarcoma	0.00066	0.00387	CcSEcCtD
Cephalexin—Leukopenia—Dactinomycin—sarcoma	0.000657	0.00385	CcSEcCtD
Cephalexin—Colitis—Epirubicin—sarcoma	0.000654	0.00384	CcSEcCtD
Cephalexin—Blood urea increased—Epirubicin—sarcoma	0.000643	0.00377	CcSEcCtD
Cephalexin—Vaginal infection—Epirubicin—sarcoma	0.000643	0.00377	CcSEcCtD
Cephalexin—Hepatobiliary disease—Etoposide—sarcoma	0.000643	0.00377	CcSEcCtD
Cephalexin—Convulsion—Thiotepa—sarcoma	0.000641	0.00376	CcSEcCtD
Cephalexin—Aplastic anaemia—Epirubicin—sarcoma	0.000639	0.00375	CcSEcCtD
Cephalexin—Agranulocytosis—Etoposide—sarcoma	0.000634	0.00372	CcSEcCtD
Cephalexin—Phosphatase alkaline increased—Doxorubicin—sarcoma	0.00063	0.0037	CcSEcCtD
Cephalexin—Vaginal inflammation—Doxorubicin—sarcoma	0.00063	0.0037	CcSEcCtD
Cephalexin—Arthralgia—Thiotepa—sarcoma	0.00063	0.00369	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000625	0.00367	CcSEcCtD
Cephalexin—Confusional state—Thiotepa—sarcoma	0.000609	0.00357	CcSEcCtD
Cephalexin—Colitis—Doxorubicin—sarcoma	0.000605	0.00355	CcSEcCtD
Cephalexin—Urinary tract disorder—Etoposide—sarcoma	0.000603	0.00353	CcSEcCtD
Cephalexin—Agitation—Vincristine—sarcoma	0.000603	0.00353	CcSEcCtD
Cephalexin—Urethral disorder—Etoposide—sarcoma	0.000598	0.00351	CcSEcCtD
Cephalexin—Vaginal infection—Doxorubicin—sarcoma	0.000595	0.00349	CcSEcCtD
Cephalexin—Blood urea increased—Doxorubicin—sarcoma	0.000595	0.00349	CcSEcCtD
Cephalexin—Nervous system disorder—Thiotepa—sarcoma	0.000592	0.00347	CcSEcCtD
Cephalexin—Aplastic anaemia—Doxorubicin—sarcoma	0.000592	0.00347	CcSEcCtD
Cephalexin—Thrombocytopenia—Thiotepa—sarcoma	0.000591	0.00347	CcSEcCtD
Cephalexin—Leukopenia—Vincristine—sarcoma	0.000587	0.00344	CcSEcCtD
Cephalexin—Thrombocytopenia—Dactinomycin—sarcoma	0.000586	0.00344	CcSEcCtD
Cephalexin—Skin disorder—Thiotepa—sarcoma	0.000586	0.00344	CcSEcCtD
Cephalexin—Erythema multiforme—Etoposide—sarcoma	0.000577	0.00338	CcSEcCtD
Cephalexin—Leukopenia—Mitoxantrone—sarcoma	0.000572	0.00335	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Epirubicin—sarcoma	0.000568	0.00333	CcSEcCtD
Cephalexin—Convulsion—Vincristine—sarcoma	0.000568	0.00333	CcSEcCtD
Cephalexin—Hepatic function abnormal—Epirubicin—sarcoma	0.000566	0.00332	CcSEcCtD
Cephalexin—Convulsion—Mitoxantrone—sarcoma	0.000553	0.00325	CcSEcCtD
Cephalexin—Immune system disorder—Etoposide—sarcoma	0.000551	0.00323	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00055	0.00322	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000546	0.0032	CcSEcCtD
Cephalexin—Arthralgia—Mitoxantrone—sarcoma	0.000544	0.00319	CcSEcCtD
Cephalexin—Anaphylactic shock—Vincristine—sarcoma	0.000535	0.00314	CcSEcCtD
Cephalexin—Dyspepsia—Thiotepa—sarcoma	0.000531	0.00312	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.000526	0.00308	CcSEcCtD
Cephalexin—Confusional state—Mitoxantrone—sarcoma	0.000526	0.00308	CcSEcCtD
Cephalexin—Nervous system disorder—Vincristine—sarcoma	0.000525	0.00308	CcSEcCtD
Cephalexin—Thrombocytopenia—Vincristine—sarcoma	0.000524	0.00307	CcSEcCtD
Cephalexin—Hepatic function abnormal—Doxorubicin—sarcoma	0.000523	0.00307	CcSEcCtD
Cephalexin—Anaphylactic shock—Mitoxantrone—sarcoma	0.000521	0.00306	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Thiotepa—sarcoma	0.000521	0.00306	CcSEcCtD
Cephalexin—Fatigue—Thiotepa—sarcoma	0.00052	0.00305	CcSEcCtD
Cephalexin—Fatigue—Dactinomycin—sarcoma	0.000516	0.00303	CcSEcCtD
Cephalexin—Thrombocytopenia—Mitoxantrone—sarcoma	0.00051	0.00299	CcSEcCtD
Cephalexin—Skin disorder—Mitoxantrone—sarcoma	0.000506	0.00297	CcSEcCtD
Cephalexin—Feeling abnormal—Thiotepa—sarcoma	0.000497	0.00292	CcSEcCtD
Cephalexin—Osteoarthritis—Epirubicin—sarcoma	0.000494	0.0029	CcSEcCtD
Cephalexin—Feeling abnormal—Dactinomycin—sarcoma	0.000494	0.00289	CcSEcCtD
Cephalexin—Gastrointestinal pain—Thiotepa—sarcoma	0.000493	0.00289	CcSEcCtD
Cephalexin—Gastrointestinal pain—Dactinomycin—sarcoma	0.00049	0.00287	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Vincristine—sarcoma	0.000488	0.00286	CcSEcCtD
Cephalexin—Urticaria—Thiotepa—sarcoma	0.000479	0.00281	CcSEcCtD
Cephalexin—Body temperature increased—Thiotepa—sarcoma	0.000477	0.0028	CcSEcCtD
Cephalexin—Abdominal pain—Thiotepa—sarcoma	0.000477	0.0028	CcSEcCtD
Cephalexin—Leukopenia—Etoposide—sarcoma	0.000475	0.00279	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000475	0.00278	CcSEcCtD
Cephalexin—Abdominal pain—Dactinomycin—sarcoma	0.000473	0.00278	CcSEcCtD
Cephalexin—Body temperature increased—Dactinomycin—sarcoma	0.000473	0.00278	CcSEcCtD
Cephalexin—Blood creatinine increased—Epirubicin—sarcoma	0.000463	0.00272	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Vincristine—sarcoma	0.000462	0.00271	CcSEcCtD
Cephalexin—Fatigue—Vincristine—sarcoma	0.000461	0.00271	CcSEcCtD
Cephalexin—Convulsion—Etoposide—sarcoma	0.00046	0.0027	CcSEcCtD
Cephalexin—Dyspepsia—Mitoxantrone—sarcoma	0.000459	0.00269	CcSEcCtD
Cephalexin—Osteoarthritis—Doxorubicin—sarcoma	0.000457	0.00268	CcSEcCtD
Cephalexin—Fatigue—Mitoxantrone—sarcoma	0.000449	0.00264	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000449	0.00263	CcSEcCtD
Cephalexin—Breast disorder—Epirubicin—sarcoma	0.000447	0.00262	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000445	0.00261	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000445	0.00261	CcSEcCtD
Cephalexin—Hypersensitivity—Thiotepa—sarcoma	0.000445	0.00261	CcSEcCtD
Cephalexin—Hypersensitivity—Dactinomycin—sarcoma	0.000441	0.00259	CcSEcCtD
Cephalexin—Gastrointestinal pain—Vincristine—sarcoma	0.000438	0.00257	CcSEcCtD
Cephalexin—Gastritis—Epirubicin—sarcoma	0.000438	0.00257	CcSEcCtD
Cephalexin—Confusional state—Etoposide—sarcoma	0.000437	0.00256	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000436	0.00256	CcSEcCtD
Cephalexin—Anaphylactic shock—Etoposide—sarcoma	0.000434	0.00254	CcSEcCtD
Cephalexin—Asthenia—Thiotepa—sarcoma	0.000433	0.00254	CcSEcCtD
Cephalexin—Asthenia—Dactinomycin—sarcoma	0.00043	0.00252	CcSEcCtD
Cephalexin—Feeling abnormal—Mitoxantrone—sarcoma	0.000429	0.00252	CcSEcCtD
Cephalexin—Blood creatinine increased—Doxorubicin—sarcoma	0.000429	0.00251	CcSEcCtD
Cephalexin—Pruritus—Thiotepa—sarcoma	0.000427	0.0025	CcSEcCtD
Cephalexin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000426	0.0025	CcSEcCtD
Cephalexin—Thrombocytopenia—Etoposide—sarcoma	0.000424	0.00249	CcSEcCtD
Cephalexin—Eosinophilia—Epirubicin—sarcoma	0.000423	0.00248	CcSEcCtD
Cephalexin—Body temperature increased—Vincristine—sarcoma	0.000423	0.00248	CcSEcCtD
Cephalexin—Abdominal pain—Vincristine—sarcoma	0.000423	0.00248	CcSEcCtD
Cephalexin—Skin disorder—Etoposide—sarcoma	0.000421	0.00247	CcSEcCtD
Cephalexin—Urticaria—Mitoxantrone—sarcoma	0.000414	0.00243	CcSEcCtD
Cephalexin—Breast disorder—Doxorubicin—sarcoma	0.000413	0.00242	CcSEcCtD
Cephalexin—Diarrhoea—Thiotepa—sarcoma	0.000413	0.00242	CcSEcCtD
Cephalexin—Abdominal pain—Mitoxantrone—sarcoma	0.000412	0.00242	CcSEcCtD
Cephalexin—Body temperature increased—Mitoxantrone—sarcoma	0.000412	0.00242	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000412	0.00242	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000412	0.00242	CcSEcCtD
Cephalexin—Diarrhoea—Dactinomycin—sarcoma	0.00041	0.0024	CcSEcCtD
Cephalexin—Pancytopenia—Epirubicin—sarcoma	0.000406	0.00238	CcSEcCtD
Cephalexin—Gastritis—Doxorubicin—sarcoma	0.000405	0.00237	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000403	0.00237	CcSEcCtD
Cephalexin—Neutropenia—Epirubicin—sarcoma	0.0004	0.00234	CcSEcCtD
Cephalexin—Dizziness—Thiotepa—sarcoma	0.000399	0.00234	CcSEcCtD
Cephalexin—Hypersensitivity—Vincristine—sarcoma	0.000394	0.00231	CcSEcCtD
Cephalexin—Eosinophilia—Doxorubicin—sarcoma	0.000391	0.0023	CcSEcCtD
Cephalexin—Hypersensitivity—Mitoxantrone—sarcoma	0.000384	0.00225	CcSEcCtD
Cephalexin—Asthenia—Vincristine—sarcoma	0.000384	0.00225	CcSEcCtD
Cephalexin—Vomiting—Thiotepa—sarcoma	0.000384	0.00225	CcSEcCtD
Cephalexin—Infestation NOS—Epirubicin—sarcoma	0.000381	0.00223	CcSEcCtD
Cephalexin—Infestation—Epirubicin—sarcoma	0.000381	0.00223	CcSEcCtD
Cephalexin—Vomiting—Dactinomycin—sarcoma	0.000381	0.00223	CcSEcCtD
Cephalexin—Rash—Thiotepa—sarcoma	0.000381	0.00223	CcSEcCtD
Cephalexin—Dermatitis—Thiotepa—sarcoma	0.00038	0.00223	CcSEcCtD
Cephalexin—Headache—Thiotepa—sarcoma	0.000378	0.00222	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000378	0.00222	CcSEcCtD
Cephalexin—Rash—Dactinomycin—sarcoma	0.000378	0.00221	CcSEcCtD
Cephalexin—Pancytopenia—Doxorubicin—sarcoma	0.000375	0.0022	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Etoposide—sarcoma	0.000374	0.0022	CcSEcCtD
Cephalexin—Asthenia—Mitoxantrone—sarcoma	0.000374	0.00219	CcSEcCtD
Cephalexin—Fatigue—Etoposide—sarcoma	0.000374	0.00219	CcSEcCtD
Cephalexin—Neutropenia—Doxorubicin—sarcoma	0.00037	0.00217	CcSEcCtD
Cephalexin—Diarrhoea—Vincristine—sarcoma	0.000366	0.00215	CcSEcCtD
Cephalexin—Hepatobiliary disease—Epirubicin—sarcoma	0.00036	0.00211	CcSEcCtD
Cephalexin—Nausea—Thiotepa—sarcoma	0.000358	0.0021	CcSEcCtD
Cephalexin—Feeling abnormal—Etoposide—sarcoma	0.000357	0.0021	CcSEcCtD
Cephalexin—Diarrhoea—Mitoxantrone—sarcoma	0.000357	0.00209	CcSEcCtD
Cephalexin—Nausea—Dactinomycin—sarcoma	0.000356	0.00209	CcSEcCtD
Cephalexin—Agranulocytosis—Epirubicin—sarcoma	0.000356	0.00209	CcSEcCtD
Cephalexin—Gastrointestinal pain—Etoposide—sarcoma	0.000354	0.00208	CcSEcCtD
Cephalexin—Dizziness—Vincristine—sarcoma	0.000354	0.00208	CcSEcCtD
Cephalexin—Infestation NOS—Doxorubicin—sarcoma	0.000353	0.00207	CcSEcCtD
Cephalexin—Infestation—Doxorubicin—sarcoma	0.000353	0.00207	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00035	0.00205	CcSEcCtD
Cephalexin—Urticaria—Etoposide—sarcoma	0.000344	0.00202	CcSEcCtD
Cephalexin—Haemoglobin—Epirubicin—sarcoma	0.000344	0.00202	CcSEcCtD
Cephalexin—Body temperature increased—Etoposide—sarcoma	0.000343	0.00201	CcSEcCtD
Cephalexin—Abdominal pain—Etoposide—sarcoma	0.000343	0.00201	CcSEcCtD
Cephalexin—Haemorrhage—Epirubicin—sarcoma	0.000342	0.00201	CcSEcCtD
Cephalexin—Hepatitis—Epirubicin—sarcoma	0.000342	0.00201	CcSEcCtD
Cephalexin—Vomiting—Vincristine—sarcoma	0.00034	0.002	CcSEcCtD
Cephalexin—Urinary tract disorder—Epirubicin—sarcoma	0.000338	0.00198	CcSEcCtD
Cephalexin—Rash—Vincristine—sarcoma	0.000337	0.00198	CcSEcCtD
Cephalexin—Dermatitis—Vincristine—sarcoma	0.000337	0.00198	CcSEcCtD
Cephalexin—Connective tissue disorder—Epirubicin—sarcoma	0.000336	0.00197	CcSEcCtD
Cephalexin—Urethral disorder—Epirubicin—sarcoma	0.000335	0.00197	CcSEcCtD
Cephalexin—Headache—Vincristine—sarcoma	0.000335	0.00197	CcSEcCtD
Cephalexin—Hepatobiliary disease—Doxorubicin—sarcoma	0.000333	0.00196	CcSEcCtD
Cephalexin—Vomiting—Mitoxantrone—sarcoma	0.000331	0.00194	CcSEcCtD
Cephalexin—Agranulocytosis—Doxorubicin—sarcoma	0.000329	0.00193	CcSEcCtD
Cephalexin—Rash—Mitoxantrone—sarcoma	0.000329	0.00193	CcSEcCtD
Cephalexin—Dermatitis—Mitoxantrone—sarcoma	0.000328	0.00193	CcSEcCtD
Cephalexin—Headache—Mitoxantrone—sarcoma	0.000326	0.00191	CcSEcCtD
Cephalexin—Erythema multiforme—Epirubicin—sarcoma	0.000323	0.0019	CcSEcCtD
Cephalexin—Hypersensitivity—Etoposide—sarcoma	0.000319	0.00187	CcSEcCtD
Cephalexin—Haemoglobin—Doxorubicin—sarcoma	0.000318	0.00187	CcSEcCtD
Cephalexin—Nausea—Vincristine—sarcoma	0.000318	0.00186	CcSEcCtD
Cephalexin—Haemorrhage—Doxorubicin—sarcoma	0.000316	0.00186	CcSEcCtD
Cephalexin—Hepatitis—Doxorubicin—sarcoma	0.000316	0.00186	CcSEcCtD
Cephalexin—Urinary tract disorder—Doxorubicin—sarcoma	0.000313	0.00183	CcSEcCtD
Cephalexin—Asthenia—Etoposide—sarcoma	0.000311	0.00182	CcSEcCtD
Cephalexin—Connective tissue disorder—Doxorubicin—sarcoma	0.000311	0.00182	CcSEcCtD
Cephalexin—Urethral disorder—Doxorubicin—sarcoma	0.00031	0.00182	CcSEcCtD
Cephalexin—Nausea—Mitoxantrone—sarcoma	0.00031	0.00182	CcSEcCtD
Cephalexin—Immune system disorder—Epirubicin—sarcoma	0.000309	0.00181	CcSEcCtD
Cephalexin—Pruritus—Etoposide—sarcoma	0.000307	0.0018	CcSEcCtD
Cephalexin—Mental disorder—Epirubicin—sarcoma	0.0003	0.00176	CcSEcCtD
Cephalexin—Erythema multiforme—Doxorubicin—sarcoma	0.000299	0.00176	CcSEcCtD
Cephalexin—Diarrhoea—Etoposide—sarcoma	0.000297	0.00174	CcSEcCtD
Cephalexin—Dizziness—Etoposide—sarcoma	0.000287	0.00168	CcSEcCtD
Cephalexin—Immune system disorder—Doxorubicin—sarcoma	0.000286	0.00168	CcSEcCtD
Cephalexin—Mental disorder—Doxorubicin—sarcoma	0.000277	0.00163	CcSEcCtD
Cephalexin—Vomiting—Etoposide—sarcoma	0.000276	0.00162	CcSEcCtD
Cephalexin—Agitation—Epirubicin—sarcoma	0.000274	0.0016	CcSEcCtD
Cephalexin—Rash—Etoposide—sarcoma	0.000273	0.0016	CcSEcCtD
Cephalexin—Dermatitis—Etoposide—sarcoma	0.000273	0.0016	CcSEcCtD
Cephalexin—Headache—Etoposide—sarcoma	0.000272	0.00159	CcSEcCtD
Cephalexin—Leukopenia—Epirubicin—sarcoma	0.000267	0.00156	CcSEcCtD
Cephalexin—Convulsion—Epirubicin—sarcoma	0.000258	0.00151	CcSEcCtD
Cephalexin—Nausea—Etoposide—sarcoma	0.000257	0.00151	CcSEcCtD
Cephalexin—Arthralgia—Epirubicin—sarcoma	0.000253	0.00149	CcSEcCtD
Cephalexin—Agitation—Doxorubicin—sarcoma	0.000253	0.00148	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000252	0.00148	CcSEcCtD
Cephalexin—Leukopenia—Doxorubicin—sarcoma	0.000247	0.00145	CcSEcCtD
Cephalexin—Confusional state—Epirubicin—sarcoma	0.000245	0.00144	CcSEcCtD
Cephalexin—Anaphylactic shock—Epirubicin—sarcoma	0.000243	0.00143	CcSEcCtD
Cephalexin—Convulsion—Doxorubicin—sarcoma	0.000239	0.0014	CcSEcCtD
Cephalexin—Nervous system disorder—Epirubicin—sarcoma	0.000238	0.0014	CcSEcCtD
Cephalexin—Thrombocytopenia—Epirubicin—sarcoma	0.000238	0.0014	CcSEcCtD
Cephalexin—Skin disorder—Epirubicin—sarcoma	0.000236	0.00138	CcSEcCtD
Cephalexin—Arthralgia—Doxorubicin—sarcoma	0.000235	0.00138	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000233	0.00137	CcSEcCtD
Cephalexin—Confusional state—Doxorubicin—sarcoma	0.000227	0.00133	CcSEcCtD
Cephalexin—Anaphylactic shock—Doxorubicin—sarcoma	0.000225	0.00132	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000221	0.0013	CcSEcCtD
Cephalexin—Nervous system disorder—Doxorubicin—sarcoma	0.00022	0.00129	CcSEcCtD
Cephalexin—Thrombocytopenia—Doxorubicin—sarcoma	0.00022	0.00129	CcSEcCtD
Cephalexin—Skin disorder—Doxorubicin—sarcoma	0.000218	0.00128	CcSEcCtD
Cephalexin—Dyspepsia—Epirubicin—sarcoma	0.000214	0.00125	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Epirubicin—sarcoma	0.00021	0.00123	CcSEcCtD
Cephalexin—Fatigue—Epirubicin—sarcoma	0.00021	0.00123	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000205	0.0012	CcSEcCtD
Cephalexin—Feeling abnormal—Epirubicin—sarcoma	0.0002	0.00117	CcSEcCtD
Cephalexin—Gastrointestinal pain—Epirubicin—sarcoma	0.000199	0.00117	CcSEcCtD
Cephalexin—Dyspepsia—Doxorubicin—sarcoma	0.000198	0.00116	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000194	0.00114	CcSEcCtD
Cephalexin—Fatigue—Doxorubicin—sarcoma	0.000194	0.00114	CcSEcCtD
Cephalexin—Urticaria—Epirubicin—sarcoma	0.000193	0.00113	CcSEcCtD
Cephalexin—Abdominal pain—Epirubicin—sarcoma	0.000192	0.00113	CcSEcCtD
Cephalexin—Body temperature increased—Epirubicin—sarcoma	0.000192	0.00113	CcSEcCtD
Cephalexin—Feeling abnormal—Doxorubicin—sarcoma	0.000185	0.00109	CcSEcCtD
Cephalexin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000184	0.00108	CcSEcCtD
Cephalexin—Hypersensitivity—Epirubicin—sarcoma	0.000179	0.00105	CcSEcCtD
Cephalexin—Urticaria—Doxorubicin—sarcoma	0.000179	0.00105	CcSEcCtD
Cephalexin—Body temperature increased—Doxorubicin—sarcoma	0.000178	0.00104	CcSEcCtD
Cephalexin—Abdominal pain—Doxorubicin—sarcoma	0.000178	0.00104	CcSEcCtD
Cephalexin—Asthenia—Epirubicin—sarcoma	0.000174	0.00102	CcSEcCtD
Cephalexin—Pruritus—Epirubicin—sarcoma	0.000172	0.00101	CcSEcCtD
Cephalexin—Diarrhoea—Epirubicin—sarcoma	0.000166	0.000975	CcSEcCtD
Cephalexin—Hypersensitivity—Doxorubicin—sarcoma	0.000166	0.000972	CcSEcCtD
Cephalexin—Asthenia—Doxorubicin—sarcoma	0.000161	0.000946	CcSEcCtD
Cephalexin—Dizziness—Epirubicin—sarcoma	0.000161	0.000942	CcSEcCtD
Cephalexin—Pruritus—Doxorubicin—sarcoma	0.000159	0.000933	CcSEcCtD
Cephalexin—Vomiting—Epirubicin—sarcoma	0.000155	0.000906	CcSEcCtD
Cephalexin—Diarrhoea—Doxorubicin—sarcoma	0.000154	0.000902	CcSEcCtD
Cephalexin—Rash—Epirubicin—sarcoma	0.000153	0.000899	CcSEcCtD
Cephalexin—Dermatitis—Epirubicin—sarcoma	0.000153	0.000898	CcSEcCtD
Cephalexin—Headache—Epirubicin—sarcoma	0.000152	0.000893	CcSEcCtD
Cephalexin—Dizziness—Doxorubicin—sarcoma	0.000149	0.000872	CcSEcCtD
Cephalexin—Nausea—Epirubicin—sarcoma	0.000144	0.000847	CcSEcCtD
Cephalexin—Vomiting—Doxorubicin—sarcoma	0.000143	0.000838	CcSEcCtD
Cephalexin—Rash—Doxorubicin—sarcoma	0.000142	0.000831	CcSEcCtD
Cephalexin—Dermatitis—Doxorubicin—sarcoma	0.000142	0.000831	CcSEcCtD
Cephalexin—Headache—Doxorubicin—sarcoma	0.000141	0.000826	CcSEcCtD
Cephalexin—Nausea—Doxorubicin—sarcoma	0.000134	0.000783	CcSEcCtD
